SAS Output

24-MAR-2017 18:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 Y 1 Recurrence Score testing 9400 8988 778 399 224 82 17 02/28/2011 440 215
            8988 778 399 224 82 17      
 
    2 Y 2 Chemo and Endocrine Therapy 4000 2401 265 129 61 25 4 02/28/2011    
        3 Endocrine Therapy Alone   2394 266 134 71 32 7      
            4795 531 263 132 57 11      
 
  S1207-Brst,Adj,Endocrine+/-Everolimus 1 Y 1 Blinded drug + Endocrine 1900 572 231 108 55 17 4 09/12/2013 466 240
        2 Blinded drug + Endocrine   573 229 111 59 24 4      
            1145 460 219 114 41 8      
 
  S1222-Brst,Fulv. +/- Ever. +/- Anastr. 1 T 1 Blinded treatment 840 12 0 0 0 0 0 05/15/2014 29 8
        2 Blinded treatment   12 0 0 0 0 0      
        3 Blinded treatment   13 0 0 0 0 0      
            37 0 0 0 0 0      
 
  S1416-Brst, TNBC/BRCA, Cis+/- ABT-888 1 Y 1 Blinded Drug + Cisplatin 333 28 28 28 21 13 3 09/15/2016 239 109
        2 Blinded Drug + Cisplatin   24 24 22 18 7 1      
            52 52 50 39 20 4      
 
  S1418-Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 Y 1 Tissue for PD-L1 testing 1000 11 11 11 11 5 1 01/18/2017 249 106
            11 11 11 11 5 1      
 
    2 Y 2 Observation 1000 2 2 2 2 2 0 01/18/2017    
        3 MK-3475 (Pembrolizumab)   3 3 3 3 1 0      
            5 5 5 5 3 0      
 
Yes A011106-Breast, Neoadj, ALTERNATE study 1 E Total Registrations   33 16 10 3 3 2 04/29/2014 257 121
            33 16 10 3 3 2      
 
  E1Z11-Brst,Genetic Predictors of AIMSS 1 E Total Registrations   138 8 2 0 0 0 08/13/2013 263 92
            138 8 2 0 0 0      
 
No A011202-Breast, Nodal XRT +/- ALND 0 E Total Registrations   107 41 24 15 5 0 03/20/2014 356 189
            107 41 24 15 5 0      
 
    1 E Total Registrations   45 20 10 7 2 1 03/20/2014    
            45 20 10 7 2 1      
 
  A011203-Breast, Adv, Tam vs Endoxifen 0 E Total Registrations   9 3 1 1 1 0 08/14/2015 240 91
            9 3 1 1 1 0      
 
    1 E Total Registrations   6 0 0 0 0 0 08/14/2015    
            6 0 0 0 0 0      
 
    2 E Total Registrations   2 1 0 0 0 0 08/14/2015    
            2 1 0 0 0 0      
 
  A011401-Breast, adj, Stage II/III HER2-, weight loss 1 E Total Registrations   23 23 23 15 5 2 10/05/2016 215 105
            23 23 23 15 5 2      
 
    2 E Total Registrations   19 19 19 14 6 1 10/05/2016    
            19 19 19 14 6 1      
 
  B51-Breast, Regional Nodal XRT 1 E Total Registrations   12 6 4 4 2 0 06/13/2014 444 227
            12 6 4 4 2 0      
 
  B55-Brst, Adj Olaparib for BRCA,TNBC 1 E Total Registrations   37 21 14 7 2 0 12/15/2014 399 182
            37 21 14 7 2 0      
 
    2 E Total Registrations   15 8 5 4 1 0 12/15/2014    
            15 8 5 4 1 0      
 
  E2112-Brst,Adv,Exemestane+/-Entinostat 1 E Total Registrations   29 16 7 3 0 0 04/01/2015 305 171
            29 16 7 3 0 0      
 
  EA1131-Brst, TNBC, Post-op Chemo vs Obs 0 E Total Registrations   6 3 1 1 1 0 11/12/2015 247 117
            6 3 1 1 1 0      
 
    1 P Total Registrations   1 1 0 0 0 0 11/12/2015    
            1 1 0 0 0 0      
 
  NRGBR003-Brst,Adj,TNBC,AC -> WP +/- Carbo 1 E Total Registrations   27 16 6 2 1 0 10/16/2015 438 217
            27 16 6 2 1 0